The Global Health Body Raises Alert Over Critical Lack of Obesity Jabs
Fewer than one in 10 people who could benefit from weight-loss injections like Wegovy can access them, states the World Health Organization as it releases its inaugural recommendations on the drugs.
Considering more than one billion people worldwide now obese, it is advocating for more widespread and fairer access to this class of drugs.
Based on forecasts, over two billion are projected to be obese by 2030 if no action is taken.
"The latest guidelines recognises that obesity is a lifelong illness that can be addressed with thorough and lifelong treatment," stated WHO director-general Tedros Adhanom Ghebreyesus.
Significant expense, constrained manufacturing, and logistical bottlenecks are major obstacles to universal availability to the injections that can aid individuals in losing significant weight, explains the body.
GLP-1 Therapy Scarcity
Even in the current best projected scenario, the supply of such drugs would only suffice for approximately 100 million people – under 10% of those who need them, according to the health organization.
The advice urges nations and manufacturers to increase availability, by strategies including licensing agreements.
The intellectual property rights on a key compound – the primary ingredient of the drug Wegovy – is due to expire in several nations in 2026.
How Obesity Jabs Operate
GLP-1 drugs replicate a biological compound to delay gastric emptying, reduce hunger and boost feelings of fullness so individuals reduce food intake.
Patients usually see weight reduction after several weeks of commencing the regular doses.
Evidence indicates people may see weight return within a year of discontinuing the medication, as their usual hunger come back.
To be carrying excess weight increases your likelihood for experiencing medical conditions, including diabetes, heart disease, stroke, and some malignancies.
Obesity impacts individuals in every country and was associated with 3.7 million fatalities worldwide in 2024, as per the WHO.
